Institutional investors purchased a net $1.2 million shares of NEO during the quarter ended March 2016, and now own 73.99% of the total float, a percentage that is typical for companies in the Medical/Nursing Services industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUMMIT CREEK ADVISORS LLC Bought 178.8 Thousand shares of Neogenomics Inc
PRINCIPAL MANAGEMENT CORP. Bought 53.1 Thousand shares of Neogenomics Inc
FOX RUN MANAGEMENT LLC Bought 21.3 Thousand shares of Neogenomics Inc